242 related articles for article (PubMed ID: 20415859)
1. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis.
Chatenoud L; You S; Okada H; Kuhn C; Michaud B; Bach JF
Clin Exp Immunol; 2010 Apr; 160(1):106-12. PubMed ID: 20415859
[TBL] [Abstract][Full Text] [Related]
2. Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?
Chatenoud L
Nat Rev Endocrinol; 2010 Mar; 6(3):149-57. PubMed ID: 20173776
[TBL] [Abstract][Full Text] [Related]
3. CD3 monoclonal antibodies: a first step towards operational immune tolerance in the clinic.
Chatenoud L; Waldmann H
Rev Diabet Stud; 2012; 9(4):372-81. PubMed ID: 23804274
[TBL] [Abstract][Full Text] [Related]
4. [One step towards restoration of self-tolerance in human autoimmune diseases].
Chatenoud L
Med Sci (Paris); 2007 Feb; 23(2):167-71. PubMed ID: 17291426
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes.
Azam A; Eisenbarth GS
Expert Opin Biol Ther; 2004 Oct; 4(10):1569-75. PubMed ID: 15461568
[TBL] [Abstract][Full Text] [Related]
6. Restoration of self-tolerance is a feasible approach to control ongoing beta-cell specific autoreactivity: its relevance for treatment in established diabetes and islet transplantation.
Chatenoud L
Diabetologia; 2001 May; 44(5):521-36. PubMed ID: 11380070
[TBL] [Abstract][Full Text] [Related]
7. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: farm lifestyles and the hygiene hypothesis.
von Mutius E
Clin Exp Immunol; 2010 Apr; 160(1):130-5. PubMed ID: 20415863
[TBL] [Abstract][Full Text] [Related]
8. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
9. Islet-Derived CD4 T Cells Targeting Proinsulin in Human Autoimmune Diabetes.
Michels AW; Landry LG; McDaniel KA; Yu L; Campbell-Thompson M; Kwok WW; Jones KL; Gottlieb PA; Kappler JW; Tang Q; Roep BO; Atkinson MA; Mathews CE; Nakayama M
Diabetes; 2017 Mar; 66(3):722-734. PubMed ID: 27920090
[TBL] [Abstract][Full Text] [Related]
10. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
[TBL] [Abstract][Full Text] [Related]
11. T-cell recognition of beta-cell autoantigens in insulin-dependent diabetes mellitus.
Kallan AA; de Vries RR; Roep BO
APMIS; 1996 Jan; 104(1):3-11. PubMed ID: 8645454
[TBL] [Abstract][Full Text] [Related]
12. [Prevent and cure insulin-dependent diabetes].
Bach JF
Pathol Biol (Paris); 2003 Apr; 51(3):151-5. PubMed ID: 12781796
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy-based strategies for the treatment of autoimmune diabetes: searching for the cure.
Phillips BE; Trucco M
Curr Pharm Des; 2011; 17(29):3217-23. PubMed ID: 21864264
[TBL] [Abstract][Full Text] [Related]
14. Gangliosides and autoimmune diabetes.
Misasi R; Dionisi S; Farilla L; Carabba B; Lenti L; Di Mario U; Dotta F
Diabetes Metab Rev; 1997 Sep; 13(3):163-79. PubMed ID: 9307889
[TBL] [Abstract][Full Text] [Related]
15. B cell depletion reduces T cell activation in pancreatic islets in a murine autoimmune diabetes model.
Da Rosa LC; Boldison J; De Leenheer E; Davies J; Wen L; Wong FS
Diabetologia; 2018 Jun; 61(6):1397-1410. PubMed ID: 29594371
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune diabetes: the role of T cells, MHC molecules and autoantigens.
Durinovic-Belló I
Autoimmunity; 1998; 27(3):159-77. PubMed ID: 9609134
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
18. Infections and autoimmune diseases.
Bach JF
J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
[TBL] [Abstract][Full Text] [Related]
19. [Principles of immunotherapy in insulin-dependent diabetes mellitus].
Bretzel RG
Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913
[TBL] [Abstract][Full Text] [Related]
20. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: controversial aspects of the 'hygiene hypothesis'.
Matricardi PM
Clin Exp Immunol; 2010 Apr; 160(1):98-105. PubMed ID: 20415858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
